Suven Life Sciences Operational Benchmarking
₹307.05-0.68%
- Market cap
- ₹8,098 crore
- P/E
- 22.5
- P/B
- 13.69
- ROE
- -78.8%
- Dividend yield
- 1.20%
Suven Life Sciences compared with sector peers on revenue, market capitalization, valuation, and return metrics.
Suven Life Sciences sector benchmarking & peer comparison
Operational and financial KPI comparison against sector peers.
| Company | LTP (₹) | P/E | Market Cap (₹ cr) | Div Yield | Qtr Sales (₹ cr) | ROCE % |
|---|---|---|---|---|---|---|
| Suven Life Sciences Limited | ₹307.05 | 22.5 | 8,098 | 1.2% | 4,500 | -78.8% |
| Median (1 Cos) | ₹307.05 | 22.5 | 8,098 | 1.2% | 4,500 | -78.8% |
Source: NSE sector index filings and financial statements. Data as of 7 October 2026. How this data is compiled.
Same Data For Peers
- Indegene Limited operational benchmarking
- Syngene International Limited operational benchmarking
- Syncom Formulations (India) Limited operational benchmarking
- Suraksha Diagnostic Limited operational benchmarking
- Supriya Lifescience Limited operational benchmarking
- Tatva Chintan Pharma Chem Limited operational benchmarking
Trade Suven Life Sciences With ATS
Track SUVEN live and place orders from the Pocket app or the Pocket Web terminal with an ATS trading and demat account.
Figures are for information only and are not investment advice or a recommendation to buy, sell or hold any security. Investments in securities are subject to market risks; read all related documents carefully before investing.